Sunah S Hwang1,2, Blair Weikel3, Jillian Adams4, Stephanie L Bourque3,2, Jaime Cabrera5, Nancy Griffith5, Anne M Hall3,2, Jessica Scott3,2, Danielle Smith3,2, Colleen Wheeler6, Jade Woodard4, Erica Wymore3,2. 1. Department of Pediatrics, School of Medicine, University of Colorado, Aurora, Colorado; sunah.hwang@childrenscolorado.org. 2. Section of Neonatology, Children's Hospital Colorado, Aurora, Colorado. 3. Department of Pediatrics, School of Medicine, University of Colorado, Aurora, Colorado. 4. Illuminate Colorado, Denver, Colorado; and. 5. Colorado Perinatal Care Quality Collaborative, Denver, Colorado. 6. Lutheran Medical Center, Wheat Ridge, Colorado.
Abstract
OBJECTIVES: To decrease the average length of stay (LOS) of opioid-exposed newborns (OENs) by 20% from baseline from April 2017 to December 2019. METHODS: The Colorado Hospitals Substance Exposed Newborn Quality Improvement Collaborative is a consortium of neonatal providers, public health experts, and legislative experts that provides infrastructure and resources for Colorado birthing hospitals to undertake initiatives focused on improving the care of OENs. The Colorado Hospitals Substance Exposed Newborn Quality Improvement Collaborative was started in September 2017 and includes 19 birthing hospitals in Colorado, with 12 contributing data to the centralized database. The interventions were focused on (1) hospital engagement and (2) increasing nonpharmacologic care (by using the Eat, Sleep, Console assessment tool; developing guidelines for breastfeeding eligibility; employing comfort measures before pharmacologic therapy; and administering opiate therapy on an as-needed basis). RESULTS: From April 2017 to December 2019, 787 OENs were identified. Among infants ≥35 weeks' gestational age without other medical diagnoses (n = 647), statistical process control charts revealed significant reduction in the primary outcome of interest, average hospital LOS, from 14.8 to 5.9 days. For all OENs, receipt of pharmacologic therapy declined from 61% to 23%. Among OENs who received pharmacologic therapy (and were ≥35 weeks' gestational age without other medical diagnoses), average LOS also declined from 21.9 to 8.0 days. CONCLUSIONS: Through standardization of OEN care focused on family engagement and nonpharmacologic care, this statewide collaborative reduced average LOS, the percentage of OENs requiring opiate therapy, and average LOS for OENs requiring opiate therapy.
OBJECTIVES: To decrease the average length of stay (LOS) of opioid-exposed newborns (OENs) by 20% from baseline from April 2017 to December 2019. METHODS: The Colorado Hospitals Substance Exposed Newborn Quality Improvement Collaborative is a consortium of neonatal providers, public health experts, and legislative experts that provides infrastructure and resources for Colorado birthing hospitals to undertake initiatives focused on improving the care of OENs. The Colorado Hospitals Substance Exposed Newborn Quality Improvement Collaborative was started in September 2017 and includes 19 birthing hospitals in Colorado, with 12 contributing data to the centralized database. The interventions were focused on (1) hospital engagement and (2) increasing nonpharmacologic care (by using the Eat, Sleep, Console assessment tool; developing guidelines for breastfeeding eligibility; employing comfort measures before pharmacologic therapy; and administering opiate therapy on an as-needed basis). RESULTS: From April 2017 to December 2019, 787 OENs were identified. Among infants ≥35 weeks' gestational age without other medical diagnoses (n = 647), statistical process control charts revealed significant reduction in the primary outcome of interest, average hospital LOS, from 14.8 to 5.9 days. For all OENs, receipt of pharmacologic therapy declined from 61% to 23%. Among OENs who received pharmacologic therapy (and were ≥35 weeks' gestational age without other medical diagnoses), average LOS also declined from 21.9 to 8.0 days. CONCLUSIONS: Through standardization of OEN care focused on family engagement and nonpharmacologic care, this statewide collaborative reduced average LOS, the percentage of OENs requiring opiate therapy, and average LOS for OENs requiring opiate therapy.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Torri D Metz; Polina Rovner; M Camille Hoffman; Amanda A Allshouse; Krista M Beckwith; Ingrid A Binswanger Journal: Obstet Gynecol Date: 2016-12 Impact factor: 7.661
Authors: Katy B Kozhimannil; Amy J Graves; Marian Jarlenski; Alene Kennedy-Hendricks; Sarah Gollust; Colleen L Barry Journal: Drug Alcohol Depend Date: 2017-03-10 Impact factor: 4.492
Authors: Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis Journal: JAMA Date: 2012-04-30 Impact factor: 56.272
Authors: Adam Newman; Gregory A Davies; Kimberly Dow; Belinda Holmes; Jessica Macdonald; Sarah McKnight; Lynn Newton Journal: Can Fam Physician Date: 2015-12 Impact factor: 3.275
Authors: Elisha M Wachman; Matthew Grossman; Davida M Schiff; Barbara L Philipp; Susan Minear; Elizabeth Hutton; Kelley Saia; Fnu Nikita; Ahmad Khattab; Angela Nolin; Crystal Alvarez; Karan Barry; Ginny Combs; Donna Stickney; Jennifer Driscoll; Robin Humphreys; Judith Burke; Camilla Farrell; Hira Shrestha; Bonny L Whalen Journal: J Perinatol Date: 2018-05-08 Impact factor: 2.521
Authors: Lori A Devlin; Leslie W Young; Walter K Kraft; Elisha M Wachman; Adam Czynski; Stephanie L Merhar; T Winhusen; Hendrée E Jones; Brenda B Poindexter; Lauren S Wakschlag; Amy L Salisbury; Abigail G Matthews; Jonathan M Davis Journal: J Perinatol Date: 2021-09-23 Impact factor: 3.225